loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Calcipotriene

    Menu

    Calcipotriene

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,071,286Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21852 / DOSAGE - OINTMENT;TOPICAL - 0.064%;0.005%

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BETAMETHASONE DIPROPIONATE(UNII: 826Y60901U)
    (BETAMETHASONE DIPROPIONATE - UNII:826Y60901U)     		BETAMETHASONE DIPROPIONATE0.643mg in 1
    CALCIPOTRIENE(UNII: 143NQ3779B)
    (CALCIPOTRIENE - UNII:143NQ3779B)     		CALCIPOTRIENE50ug in 1

    Inactive Ingredients

    Ingredient Name
    LEO Pharma Inc.
    Perrigo New York Inc
    Sandoz Inc.
    Warner Chilcott (US), LLC
    .ALPHA.-TOCOPHEROL, DL-(7QWA1RIO01) 
    ALPHA-TOCOPHEROL, DL-(7QWA1RIO01)   
    BUTYLATED HYDROXYTOLUENE(1P9D0Z171K)  
    DIAZOLIDINYL UREA(H5RIZ3MPW4)   
    MEDIUM-CHAIN TRIGLYCERIDES(C9H2L21V7U)   
    MINERAL OIL(T5L8T28FGP) 
    PETROLATUM(4T6H12BN9U)
    POLYPROPYLENE GLYCOL 11 STEARYL ETHER(S4G2J0Y0LG)   
    PPG-11 STEARYL ETHER(S4G2J0Y0LG)